,,ii  #aad? ,,congress  #a/ ,session    
,s4 #ahgh  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,july #bh1 #bjae ,mr4  
,casey 7= himself & ,mr4 ,isakson7      
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to ext5d ! p$iatric priority
 review v\*] program4  #a4 ,%ort title  
,?is ,act may be cit$ z ! ,advanc+ ,hope
 ,act ( #bjae4  #b4 ,reau?orization (   
program = priority review ,to enc\rage  
treatm5ts = r>e p$iatric diseases       
,section #ebi ( ! ,f$]al ,food1 ,drug1 &
 ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff7 
is am5d$-- 7#a7 9 subsection 7a7--  7,a7
 by am5d+ p>agraph 7#c7 to read z       
foll[s3  7#c7 ,r>e p$iatric disease ,!  
t]m r>e p$iatric disease means any ( !  
foll[+3  7,a7 ,a disease t meets ea* ( !
 foll[+ crit]ia3 7i7 ,! disease prim>ily
 affects individuals ag$ f bir? to #ah  
ye>s1 includ+ age gr\ps (t5 call$       
neonates1 infants1 *ildr51 & adolesc5ts4
  7ii7 ,! disease is a r>e disease or   

condition1 )9 ! mean+ ( section #ebf4   
7,b7 ,any =m ( sickle cell disease4     
7,c7 ,any p$iatric canc]s4  2 &  7,b7 9 
p>agraph 7#d7--  7i7 9 subp>agraph 7,e71
 by /rik+ & at ! end2  7ii7 9           
subp>agraph 7,f71 by /rik+ ! p]iod at ! 
end & ins]t+ 2 &2 &  7iii7 by add+ at ! 
end ! foll[+3  7,g7 is = a drug or      
biological product = :i* a priority     
review v\*] has n be5 issu$ "u section  
#ebd 7relat+ to tropical disease        
products74  2  7#b7 9 subsection 7b71 by
 /rik+ p>agraph 7#e72 &  7#c7 9         
subsection 7d77#b71 9 ! second s5t5ce1  
by /rik+ ! p]iod & ins]t+ 1 b ! sponsor 
( a drug t int5ds to reque/ a priority  
review v\*] "u ?is section %all notify !
 ,secret>y ( su* int5t ^u submission (  
an application "u section #eje or       
section #cea ( ! ,public ,heal? ,s]vice 
,act t is ! basis ( su* reque/44